Marine Drugs (Oct 2014)

Modification of Marine Natural Product Ningalin B and SAR Study Lead to Potent P-Glycoprotein Inhibitors

  • Chao Yang,
  • Iris L. K. Wong,
  • Wen Bin Jin,
  • Tao Jiang,
  • Larry M. C. Chow,
  • Sheng Biao Wan

DOI
https://doi.org/10.3390/md12105209
Journal volume & issue
Vol. 12, no. 10
pp. 5209 – 5221

Abstract

Read online

In this study, new marine ningalin B analogues containing a piperazine or a benzoloxy group at ring C have been synthesized and evaluated on their P-gp modulating activity in human breast cancer and leukemia cell lines. Their structure-activity relationship was preliminarily studied. Compounds 19 and 20 are potent P-gp inhibitors. These two synthetic analogues of permethyl ningalin B may be potentially used as effective modulators of P-gp-mediated drug resistance in cancer cells.

Keywords